Keyphrases
Extremity Soft Tissue Sarcoma
100%
Proton
100%
Proton Therapy
100%
Photon Therapy
100%
Ultra-hypofractionated
100%
Soft Tissue Sarcoma
60%
Radiation Therapy
60%
Organs at Risk
60%
Clinical Target Volume
60%
Integral Dose
60%
Femur
40%
Femoral Head
40%
Mean Dose
40%
Target Coverage
40%
Prescription Drugs
20%
Adult Patients
20%
Therapeutic Agents
20%
Potential Gains
20%
Single Institution
20%
Lower Extremity
20%
Neoadjuvant Therapy
20%
Previously Treated
20%
Student's T-test
20%
Intensity-modulated Radiation Therapy
20%
Dose Constraints
20%
Heterogeneity Index
20%
Scanning Beam
20%
Treatment Planning System
20%
International Commissions
20%
Prescribed Dose
20%
Adjacent Organ
20%
Volume Coverage
20%
Conformity Index
20%
Proximal Joints
20%
Organs at Risk Doses
20%
Risk Constraints
20%
Neoadjuvant Radiation Therapy
20%
Dosimetric Benefits
20%
Photon Radiation
20%
Measurement Report
20%
RayStation
20%
Medicine and Dentistry
Soft Tissue Sarcoma
100%
Proton Therapy
100%
Photon Therapy
100%
Radiation Therapy
60%
Femoral Head
40%
Neoadjuvant Therapy
20%
Student T Test
20%
Treatment Planning
20%
Intensity Modulated Radiation Therapy
20%
Adult Soft Tissue Sarcoma
20%